Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.5700
-0.0195 (-3.31%)
At close: Aug 6, 2026
Vaxart Employees
Vaxart had 65 employees as of December 31, 2025. The number of employees decreased by 40 or -38.10% compared to the previous year.
Employees
65
Change (1Y)
-40
Growth (1Y)
-38.10%
Revenue / Employee
$3,932,446
Profits / Employee
$570,723
Market Cap
137.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -40 | -38.10% |
| Dec 31, 2024 | 105 | -4 | -3.67% |
| Dec 31, 2023 | 109 | -55 | -33.54% |
| Dec 31, 2022 | 164 | 54 | 49.09% |
| Dec 31, 2021 | 110 | 82 | 292.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Northwest Biotherapeutics | 105 |
| CytoDyn | 13 |
| Nuo Therapeutics | 10 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
Vaxart News
- Just now - Vaxart Earnings release: Q2 2026 - Filings
- Just now - Vaxart Quarterly report: Q2 2026 - Filings
- 7 days ago - Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET - GlobeNewsWire
- 16 days ago - Vaxart to Participate in BTIG Biotechnology Conference 2026 - GlobeNewsWire
- 20 days ago - Vaxart Announces Results of Annual Meeting of Stockholders - GlobeNewsWire
- 21 days ago - Vaxart Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Vaxart reports data from sentinel safety cohort of oral COVID-19 vaccine trial - TheFly
- 4 weeks ago - Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine - GlobeNewsWire